Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 20522  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (38 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  


  In this Article
 »  Abstract
 »  Introduction
 »  Material and Methods
 »  Results
 »  Discussion
 »  Conclusion
 »  References

 Article Access Statistics
    Viewed13010    
    Printed222    
    Emailed12    
    PDF Downloaded197    
    Comments [Add]    
    Cited by others 10    

Recommend this journal

   
ORIGINAL ARTICLE
Year : 2003  |  Volume : 51  |  Issue : 4  |  Page : 490-492

Percutaneous vertebroplasty: An experience of 31 procedures


Department of Neurosurgery, K.G’s Medical College, Lucknow - 226003

Correspondence Address:
Department of Neurosurgery, K.G’s Medical College, Lucknow - 226003
mazarhusain@hotmail.com

  »  Abstract

A prospective study of 31 percutaneous vertebroplasty procedures (PVP) in 22 patients treated during January 2000 to December 2001 is presented. PVP was performed using polymethylmethacrylate (PMMA) to treat vertebral collapse due to osteoporosis and vertebral metastasis, to obtain analgesia and spinal stabilization. We analyze the efficacy and complications related to the procedure. PVP is a safe, effective and a daycare surgery. It can be performed under local anesthesia and has minimal and manageable complications.

How to cite this article:
Nirala A P, Vatsal D K, Husain M, Gupta C, Chawla J, Kumar V, Thamman D, Agarwal A. Percutaneous vertebroplasty: An experience of 31 procedures. Neurol India 2003;51:490-2


How to cite this URL:
Nirala A P, Vatsal D K, Husain M, Gupta C, Chawla J, Kumar V, Thamman D, Agarwal A. Percutaneous vertebroplasty: An experience of 31 procedures. Neurol India [serial online] 2003 [cited 2020 Aug 15];51:490-2. Available from: http://www.neurologyindia.com/text.asp?2003/51/4/490/5021



  »   Introduction Top


Vertebrae give support to the body in sitting, standing and walking. With increase in the life expectancy, an increasing number of elderly persons have vertebral collapse either due to osteoporosis or metastasis. Vertebral collapse frequently causes persistent and often excruciating pain which significantly impairs mobility and the quality of life. Osteoporosis, steroid medication, bony metastasis and vertebral hemangiomas are the main causes of vertebral collapse. External bracing, analgesics, rest and observation may ameliorate pain in some patients, but in others a constant administration of narcotics is necessary.
Surgical decompression and placement of polymethylmethacrlylate (PMMA) or autologous bone graft have been used in the past for the management of neoplastic compression fractures,[2],[3],[4] giant cell tumors of long bones,[5],[6] and vertebral heamangiomas.[7] Percutaneous vertebroplasty was first performed in 1984 in France by Deramond et al[1],[8],[9] in a vertebral angioma to obtain analgesia and spinal stabilization. Till date the published data has been from the western population and the general results have been excellent.


  »   Material and Methods Top

A prospective study was carried out in the department of Neurosurgery, King George's Medical College, Lucknow from January 2000 to December 2001. Eligible patients were treated for disabling back pain and/or impaired mobility secondary to vertebral collapse of varying etiology. All were refractory to conservative therapy.
The patients underwent an elaborate physical and radiological examination. Patients in whom the pain was not localized to the site of the fracture were excluded from the study. Patients having radiculopathy and compressive myelopathy or a suspicion of Pott's spine were also excluded from the study. Active infection in the areas of planned vertebroplasty was a contraindication for treatment.

Vertebroplasty technique
The patient is placed in a prone position on the angiography table. Under appropriate monitoring, the patient is sedated using a cocktail of diazepam, promethazine and pentazocine (1 amp each) and/or midazolam. Using aseptic precautions, the vertebral body to be treated is localized under C-arm image intensifier. Local anesthesia using xylocaine is used for the overlying skin and tissues in the trajectory of injection. A small skin incision is made with no. 11 scalpel blade. A disposable 11-G Jamshidi needle is positioned with its tip in the center of oval and is advanced until the stylet tip abuts the bone. Under radiographic control the needle is advanced with a slight twisting motion through the cortex. Care must be taken not to violate the anterior cortical wall or the endplates. The stylet tip is placed at or near the junction of the anterior and middle third of the vertebral body in midline.
Before injecting the PMMA, venography is done to exclude needle placement directly within the basivertebral venous complex and to ensure continuity of the posterior vertebral wall as evidenced by containment of the contrast material within bony trabeculae. Injection of 5 ml of iohexol (omnipaque 300) was used to confirm the location of the tip of the needle.
Bone biopsy is performed through the same Jamshidi needle in cases where a malignant etiology is suspected. Codman Cranioplastic, type I (slow-setting) material (CMW Laboratories, Blackpool, England) was found to be the most suitable. The contents consist of a powder PMMA (polymethylmethacrylate) and a liquid PMMA (solvent monomer). The powder is placed into a bowl and mixed with 1 teaspoon (5 g) of sterile barium sulphate powder and/or 1 g tungsten powder to increase radio-opacity. One half of the liquid agent is aspirated into a plastic syringe and the remaining portion is left in the glass bottle. About 10 g of mixed powder is taken in a separate bowl and the liquid agent is added and thoroughly stirred to make a consistency of toothpaste. The material is then poured into a 2 ml plastic syringe, which is tightly attached to the shaft port of the Jamshidi needle and injected by one operator guided by pressure required to inject and under C-arm image intensifier control to see homogenous filling of vertebra, while the second operator loads another syringe [Figure - 1]. The injection pressure required to push the material increases over time as the vertebral body fills and the bone cement consolidates. If the passage of material into the venous system is noted, the injection is halted while the material attains a thicker consistency. The injection is continued until hemivertebral or holovertebral filling is achieved, no material can be pushed into the body or extravasation is observed into the veins or disc and epidural spaces. Upon completing the injection, the needle is removed. The contralateral hemivertebra is then treated in similar fashion, if vertebral filling is less than 50%. More than one vertebra can be treated in single setting, depending on the patient's tolerance.
After the procedure, the patient is placed in a supine position for 2 hours to allow setting of bone cement prior to axial loading. The patient is made ambulatory overnight and is discharged 24 hours later from the hospital following clinical and radiological assessment.


  »   Results Top


The procedure was performed in 22 consecutive patients (10 males, 12 females) involving 31 vertebrae (lower thoracic-13, lumbar-18). Eleven females were in the postmenopausal group (11 out of 12). Most patients were of the elderly age group with mean age of 59 years (range 35-78 years). Twenty patients belonged to the osteoporotic group (90.1%) whereas 2 patients belonged to the metastatic group (1 from carcinoma of the lung and 1 from carcinoma of the cervix). All the patients presented with severe intractable pain with varying degree of impaired mobility of relatively longer duration (mean 1½ yrs). Both the patients of the metastatic group presented with clinical and radiological features of spinal cord compression.
The procedure was successful in 21 patients. In 1 patient it was abandoned due to rapid extravasation of dye and bone cement in epidural space. The unilateral transpedicular approach was successful in the majority of vertebrae whereas the bilateral approach was needed in 4 vertebrae. The majority (68%) of the patients were treated for 1 level while 6 patients were treated for 2 levels and 1 patient was treated for 4 levels in 2 stages. The amount of bone cement injected per vertebral body varied from 2 ml to 8 ml with an average of 5 ml. Both the patients of the metastatic group required biopsy before PVP and underwent a decompressive laminectomy the following day.
The clinical response to the procedure was assessed immediately after the procedure and after 24 hours. The verbal expression of perceived pain, amount and/or type of pain medication given, and changes in the activity level (Odom's Criteria) were monitored. Twelve patients (57.1%) were cured completely whereas 8 (38.1%) obtained significant pain relief and improved mobility within 24 hours. One patient (4.8%) had no significant relief. In 1 patient the procedure was abandoned. Both the patients of the metastatic group improved completely in terms of neurological status and backache within 15 days.
Complications were encountered in 2 patients (9.1%). In 1 patient the procedure was abandoned due to extravasation of dye and bone cement in perivertebral veins and disc and epidural spaces. One patient developed allergic reactions in the form of severe itching and generalized eruptions after 24 hours. One patient had intense pain just after injection of bone cement. One patient developed retention of urine. Both the latter complications subsided within a week of symptomatic treatment. Follow-up of the patients was done at 6 months and 1 year, clinically and radiologically. No recurrence of pain and further vertebral collapse was seen during mean follow-up of 1 year [Table:1].


  »   Discussion Top

The western experience with percutaneous vertebroplasty has described 90-100% pain relief for the treatment of osteoporotic fractures.[18],[19],[20] The complications of the treatment were 0-5.4% and most were minor. It has also been used in the treatment of symptomatic and aggressive hemangiomas and vertebral column metastasis. Our experience in performing vertebroplasty with no significant complications further validates these earlier studies. Osteoporosis is the most common etiology of vertebral collapse followed by malignancy, especially metastasis.[12],[13],[14] Elderly age, postmenopausal status and prolonged steroid intake are the main factors accelerating osteoporotic collapse. All the findings in the present series are consistent with the previous studies.
Two types of patients are considered for treatment, those with chronic pain refractory to medical therapy and bracing and those with severe disabling pain caused by fractures. Severe cardiopulmonary disease, coagulopathy and cord compression are contraindications to vertebroplasty. Severe vertebral compression may also be a contraindication to treatment, because the vertebra may be compressed to such a degree that needle placement and cement injection becomes impossible. An absolute degree of vertebral compression that precludes treatment cannot be defined. An upper thoracic vertebra compressed by 50% may be impossible to treat safely, yet a lumbar vertebra compressed by 75% may still be treated because the remaining height is significant.
The majority of vertebral levels (87%) required unilateral PVP to achieve the adequate goal of homogenous vertebral filling with bone cement. When PMMA fills less than 50% of the vertebral body, a bilateral approach is required.[11] Usually 2.5 ml to 11 ml with mean of 7 ml bone cement was required to achieve the goal.[11] The magnitude of strength increased and the clinical result do not correlate with the volume of cement injected but depend upon distribution, which packs the trabecular network.[15]
In a study conducted on 274 patients, successful results were obtained in more than 90% of cases of osteoporosis and vertebral angiomas, whereas successful results were obtained in more than 80% in malignant spinal tumors.[11] The results in the present series were comparable to the previous studies in the osteoporotic group while it was different in the malignant group, though it couldn't be concluded exactly because of the small number of patients.
The complication rate for this procedure has been very low in other series,[11],[13],[14],[16] ranging from 0% to 10% depending on the initial indications of PVP. The complications are uncommon in patients with vertebral angiomas (2% to 5%) and osteoporotic lesions (1% to 3%) and can be avoided by a good technique. In patients with spinal malignant tumors, the complications of PVP are more frequent (10%). Various complications like pulmonary embolism, bleeding, radiculopathy, neurological deficits, rib fractures, infections and anesthetic complications[11],[12],[17] have been described but none of the above complications were seen in this study. Allergic reaction seen in 1 patient, might be due to dye or bone cement. Another patient experienced severe intense pain just after injection followed by retention of urine without sensory-motor deficit, which might be due to thermal injury (heat developed during bone setting) though the exact etiology remained elusive. Both the above complications have not been seen in earlier series.


  »   Conclusion Top


Vertebroplasty is an effective new tool in the treatment of osteoporotic and neoplastic compression fractures. 

  »   References Top

1.Deramond H, Darrason R, Galibert P. La vertebroplastie percutanee acrylique dans le traitment des haemangiomes vertebraux agressifs. Rachis 1989;1:143-53.   Back to cited text no. 1    
2.Sundaresan N, Galicich JH, Lane JM, Bains MS, McCormack P. Treatment of neoplastic epidural cord compression by vertebral body resection and stabilization. J Neurosurg 1985;63:676-84.  Back to cited text no. 2  [PUBMED]  
3.Harrington K. Anterior decompression and stabilization of the spine as a treatment for vertebral collapse and spinal cord compression from metastatic malignancy. Clin Orthop Rel Res 1988;233:177-97.  Back to cited text no. 3    
4.Cybulski GM. Methods of surgical stabilization for metastatic disease of the spine. Neurosurgery 1989;25:240-52.  Back to cited text no. 4    
5.Persson BM, Ekelund L, Lovdahl R, Gunterberg B. Favourable results of acrylic cementation for giant cell tumors. Acta Orthop Scand 1984;55:209-14.  Back to cited text no. 5  [PUBMED]  
6.O'Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ. Recurrence of giant cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg 1994;76:1827-33.  Back to cited text no. 6  [PUBMED]  
7.Nicola N, Lins E. Vertebral haemangiomas: Retrograde embolization- stabilization with methymethacrylate. Surg Neurol 1987;27:481-6.  Back to cited text no. 7  [PUBMED]  
8.Galibert P, Deramond H, Rosat P, et al. Note preliminaire Sur le traitment des angiomes vertebraux par vertebroplastie percutanee. Neurochirurgie 1987;233:166-8.  Back to cited text no. 8    
9.Deramond H, Galibert P, Debussche, et al. Percuatneous vertebroplasty with methylmethacrylate: Technique, Method, Results [abstract]. Radiology 1990. Vol. 117. pp. 352.  Back to cited text no. 9    
10.Lyles KW. Management of patients with vertebral compression fractures (Review). Pharmacotherapy 1999;19:21s-4s.   Back to cited text no. 10    
11.Deramond H, Depriester C, Galibert P, et al. Percutaneous vertebroplasty with PMMA : Technique, Indications and Results. Radiolo Clin N Am 1998;36:533-46.  Back to cited text no. 11    
12.Cortet B, Cotten A, Boutry N, Flipo RM, Duquesnoy B, Chastanet P, et al. Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures : an open prospective study. J Rheumatol 1990;26:2222-8.   Back to cited text no. 12    
13.Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine 2000;25:923-8.  Back to cited text no. 13  [PUBMED]  [FULLTEXT]
14.Jensen ME, Evans AJ, Mathis JM, Kallmes DF, Cloft HJ, Dion JE. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: Technical aspects. AJNR Am J Neuroradiol 1997;18:1897-904.   Back to cited text no. 14  [PUBMED]  [FULLTEXT]
15.Gishen P, Dean JR, Ison KT, et al. The Strengthening effect of Percutaneous vertebroplasty. Clin Radio 2000;55:471-6.  Back to cited text no. 15    
16.Martin JB, Jean B, Sugiu K, San Millan Ruiz D, Piotin M, Murpy K, et al. Vertebroplasty : Clinical experience and follow-up results. Bone 1999;25:11s-5s.   Back to cited text no. 16    
17.Amar AP, Larsen DW, Esnaashari N, Albuquerque FC, Lavine SD, Teitelbaum GP. Percutaneous transpedicular polymethylmethacrylate vertebroplasty for the treatment of spinal compression fractures. Neurosurgery 2001;49:1105-15.   Back to cited text no. 17    
18.Bascoulerguue Y, Duquesnel J, Leclercq R, et al. Percutaneous injection of methylmethacrylate in thevertebral body for the treatment of various diseases. Percutaneous vertebroplasty (Abstract). Radiology 1988;169:372.  Back to cited text no. 18    
19.Chiras J, Deramond H. Complications des vertebroplasties. In: Saillant G, Laville C, editors. Echecs et complications de la Chirurgie du Rachis. Chirurgie de Reprise. Paris: Sauramps Medical; 1995. pp. 149-53.  Back to cited text no. 19    
20.Gangi A, Kastler B, Dietemann JL. Percutaneous vertebroplasty guided by a combination of CT and fluoroscopy. AJNR Am J Neuroradiol 1994;15:83-6.  Back to cited text no. 20    

 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow